76.61
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $76.61, with a volume of 3.32M.
It is up +2.08% in the last 24 hours and up +1.12% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$75.05
Open:
$75.41
24h Volume:
3.32M
Relative Volume:
1.48
Market Cap:
$36.86B
Revenue:
$10.19B
Net Income/Loss:
$1.05B
P/E Ratio:
36.40
EPS:
2.1044
Net Cash Flow:
$1.38B
1W Performance:
-1.34%
1M Performance:
+1.12%
6M Performance:
-12.49%
1Y Performance:
-10.47%
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ALC
Alcon Inc
|
76.61 | 36.86B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
ISRG
Intuitive Surgical Inc
|
561.61 | 195.76B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
192.72 | 54.34B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
RMD
Resmed Inc
|
250.75 | 35.60B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
271.07 | 18.54B | 2.96B | 487.70M | 344.00M | 6.6758 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
STAAR Surgical Stock (STAA) Opinions on Alcon Merger Developments - Quiver Quantitative
Global Surgical Microscopes Market to Surpass USD 2.59 Billion by 2030 | MarketsandMarkets™ - GlobeNewswire Inc.
Alcon Inc. (0A0D.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Why Alcon Inc. Ordinary Shares stock appears on watchlistsTrade Analysis Summary & Scalable Portfolio Growth Ideas - newser.com
Is Alcon Inc. Ordinary Shares stock worth holding before Fed meeting2025 Bull vs Bear & Technical Pattern Based Buy Signals - newser.com
Published on: 2025-11-21 00:43:22 - newser.com
Will Alcon Inc. stock see PE expansion2025 Volatility Report & Growth-Oriented Investment Plans - newser.com
Is Alcon Inc. Ordinary Shares stock a top dividend aristocrat candidate2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Why analysts maintain buy rating on Alcon Inc. (2U3) stockTrade Risk Assessment & Low Risk High Win Rate Picks - newser.com
Will Alcon Inc. Ordinary Shares stock deliver compounding returnsWall Street Watch & Long-Term Capital Growth Ideas - newser.com
Why Alcon Inc. stock remains a top recommendationTrade Exit Summary & Technical Confirmation Trade Alerts - newser.com
Published on: 2025-11-19 22:41:50 - newser.com
Is Alcon Inc. (2U3) stock in buy zone after pullbackWeekly Stock Summary & Capital Efficient Trading Techniques - newser.com
Alcon Inc. stock momentum explainedGold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
Can Alcon Inc. (2U3) stock surprise with quarterly resultsQuarterly Risk Review & Weekly Momentum Stock Picks - newser.com
Broadwood Partners Highlights Board Dissent Over STAAR Surgical's Amended Alcon Deal Ahead of December Vote - MarketScreener
Is Alcon Inc. still worth holding after the dip2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
Will Alcon Inc. (2U3) stock test record highs in 2025July 2025 Fed Impact & Daily Chart Pattern Signal Reports - newser.com
Published on: 2025-11-19 13:47:44 - newser.com
How dovish Fed policy supports Alcon Inc. (2U3) stockTrade Entry Report & Low Drawdown Momentum Trade Ideas - newser.com
Chart based analysis of Alcon Inc. trendsWeekly Trade Analysis & Reliable Trade Execution Plans - newser.com
Published on: 2025-11-19 09:16:32 - newser.com
Will Alcon Inc. Ordinary Shares stock extend growth storyJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
Published on: 2025-11-19 04:22:40 - newser.com
Published on: 2025-11-19 03:53:44 - newser.com
Published on: 2025-11-18 16:53:46 - newser.com
Will Alcon Inc. stock return to pre crisis levelsQuarterly Trade Report & High Win Rate Trade Tips - newser.com
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):